DK0724583T3 - Pyridazino-quinolin-forbindelser - Google Patents

Pyridazino-quinolin-forbindelser

Info

Publication number: DK0724583T3
Authority: DK; Denmark
Prior art keywords: phenyl; deriv; substd; opt; furyl
Prior art date: 1993-10-22

Application number

DK94930275T

Other languages

English (en)

Inventor

Thomas Michael Bare

Richard Bruce Sparks

James Roy Empfield

Timothy Wayne Davenport

Jeffrey Alan Mckinney

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-22

Filing date

1994-10-20

Publication date

2001-03-05

1993-10-22 Priority claimed from GB939321854A external-priority patent/GB9321854D0/en

1994-08-25 Priority claimed from GB9417171A external-priority patent/GB9417171D0/en

1994-10-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-03-05 Application granted granted Critical

2001-03-05 Publication of DK0724583T3 publication Critical patent/DK0724583T3/da

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
125000002947 alkylene group Chemical group 0.000 abstract 2
125000005605 benzo group Chemical group 0.000 abstract 2
125000002541 furyl group Chemical group 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
125000005842 heteroatom Chemical group 0.000 abstract 2
125000004076 pyridyl group Chemical group 0.000 abstract 2
RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
241000689227 Cora <basidiomycete fungus> Species 0.000 abstract 1
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003302 alkenyloxy group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000005133 alkynyloxy group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
OHZYAOYVLLHTGW-UHFFFAOYSA-N pyrido[3,2-c]pyridazine Chemical class C1=CN=NC2=CC=CN=C21 OHZYAOYVLLHTGW-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Quinoline Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK94930275T 1993-10-22 1994-10-20 Pyridazino-quinolin-forbindelser DK0724583T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939321854A GB9321854D0 (en)	1993-10-22	1993-10-22	Pyridazino quinoline compounds
GB9417171A GB9417171D0 (en)	1994-08-25	1994-08-25	Pyridazino quinoline compounds
PCT/GB1994/002295 WO1995011244A1 (en)	1993-10-22	1994-10-20	Pyridazino quinoline compounds

Publications (1)

Publication Number	Publication Date
DK0724583T3 true DK0724583T3 (da)	2001-03-05

Family

ID=26303731

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK00101917T DK1004582T3 (da)	1993-10-22	1994-10-20	Pyradazinoquinolinforbindelser
DK94930275T DK0724583T3 (da)	1993-10-22	1994-10-20	Pyridazino-quinolin-forbindelser

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK00101917T DK1004582T3 (da)	1993-10-22	1994-10-20	Pyradazinoquinolinforbindelser

Country Status (29)

Country	Link
US (3)	US5744471A (da)
EP (2)	EP0724583B1 (da)
JP (1)	JP3583132B2 (da)
KR (1)	KR100261209B1 (da)
CN (1)	CN1053189C (da)
AT (2)	ATE198072T1 (da)
AU (2)	AU688393B2 (da)
CA (1)	CA2171332A1 (da)
CZ (1)	CZ292311B6 (da)
DE (2)	DE69426422T2 (da)
DK (2)	DK1004582T3 (da)
ES (2)	ES2154686T3 (da)
FI (2)	FI113865B (da)
GB (1)	GB9420590D0 (da)
GR (1)	GR3035080T3 (da)
HU (1)	HUT74161A (da)
IL (1)	IL111266A (da)
MY (2)	MY124316A (da)
NO (1)	NO306995B1 (da)
NZ (2)	NZ329303A (da)
PL (1)	PL180679B1 (da)
PT (2)	PT724583E (da)
RU (1)	RU2168511C2 (da)
SG (2)	SG59971A1 (da)
SI (2)	SI1004582T1 (da)
SK (1)	SK282491B6 (da)
TW (1)	TW406082B (da)
UA (1)	UA60291C2 (da)
WO (1)	WO1995011244A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL111266A (en) *	1993-10-22	2002-03-10	Zeneca Ltd	2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9422894D0 (en) *	1994-11-12	1995-01-04	Zeneca Ltd	Pyridazino quinoline compounds
US6214826B1 (en)	1994-11-12	2001-04-10	Zeneca Limited	Pyridazino quinoline compounds
GB9507318D0 (en) *	1995-04-07	1995-05-31	Zeneca Ltd	Alpha substituted pyridazino quinoline compounds
US6730675B2 (en)	1999-12-23	2004-05-04	Astrazeneca Ab	Compounds and methods for the treatment of pain
US6787547B2 (en)	1999-12-23	2004-09-07	Astrazeneca Ab	Compound and method for the treatment of pain
US20030176435A1 (en) *	2002-12-17	2003-09-18	Brown Dean Gordon	Compounds and methods for the treatment of pain
EP1244664A1 (en) *	1999-12-23	2002-10-02	AstraZeneca AB	Compounds and methods for the treatment of pain
JP2003518500A (ja) *	1999-12-23	2003-06-10	アストラゼネカ・アクチエボラーグ	痛みの処置のための方法および組成物
NZ519389A (en) *	1999-12-23	2004-05-28	Astrazeneca Ab	Method and composition for the treatment of pain
WO2001047923A1 (en) *	1999-12-23	2001-07-05	Astrazeneca Ab	Compounds and methods for the treatment of pain
US6943165B2 (en) *	1999-12-23	2005-09-13	Astrazeneca Ab	Compound and method for the treatment of pain
SK8792002A3 (en) *	1999-12-23	2003-05-02	Astrazeneca Ab	Quinoline-based compound, pharmaceutical composition containing same and use thereof
AU2420201A (en) *	1999-12-23	2001-07-09	Astrazeneca Ab	Compounds and methods for the treatment of pain
EP1577311A1 (en) *	1999-12-23	2005-09-21	AstraZeneca AB	Salts of a pyridazino aquinoline derivative and use for the treatment of pain
EP1244660B1 (en) *	1999-12-23	2006-03-22	AstraZeneca AB	Methods and compositions for the treatment of pain
US6403818B1 (en)	2000-02-28	2002-06-11	Eisai Co., Ltd.	Process for producing α-hydroxy-carbonyl compound
EP1325005A1 (en) *	2000-09-29	2003-07-09	AstraZeneca AB	1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain
JP2004509964A (ja) *	2000-09-29	2004-04-02	アストラゼネカ・アクチエボラーグ	７−クロロ−４−ヒドロキシ−２−（２−ピリジルエチル）−１，２，５，１０−テトラヒドロピリダジノ［４，５−ｂ］キノリン−１，１０−ジオン及び疼痛治療のためのその使用
AU2001292500A1 (en) *	2000-09-29	2002-04-08	Astrazeneca Ab	1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
DE60119949T2 (de)	2000-09-29	2007-04-26	Astrazeneca Ab	1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE ANWENDUNG IN DER BEHANDLUNG VON SCHMERZEN
WO2002096879A1 (en) *	2001-05-31	2002-12-05	Sanofi-Synthelabo	Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
EP1655301B1 (en)	2003-08-04	2015-03-11	Valery Khazhmuratovich Zhilov	Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
PL1773816T3 (pl)	2004-06-24	2015-06-30	Vertex Pharma	Modulatory transporterów posiadających kasetę wiążącą ATP
US8354427B2 (en)	2004-06-24	2013-01-15	Vertex Pharmaceutical Incorporated	Modulators of ATP-binding cassette transporters
EP1979367A2 (en) *	2005-12-24	2008-10-15	Vertex Pharmaceuticals Incorporated	Quinolin-4-one derivatives as modulators of abc transporters
JP5409010B2 (ja)	2005-12-28	2014-02-05	バーテックスファーマシューティカルズインコーポレイテッド	Ｎ−［２，４−ビス（１，１−ジメチルエチル）−５−ヒドロキシフェニル］−１，４−ジヒドロ−４−オキソキノリン−３−カルボキサミドの固体形態
US20100074949A1 (en)	2008-08-13	2010-03-25	William Rowe	Pharmaceutical composition and administration thereof
US12458635B2 (en)	2008-08-13	2025-11-04	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administrations thereof
MX361711B (es)	2009-03-20	2018-12-14	Vertex Pharmaceuticals Incorporated Star	Proceso para producir moduladores del regulador de conductancia transmembrana de fibrosis quistica.
US8802700B2 (en)	2010-12-10	2014-08-12	Vertex Pharmaceuticals Incorporated	Modulators of ATP-Binding Cassette transporters
CA2865519C (en)	2012-02-27	2018-01-02	Vertex Pharmaceuticals Incorporated	Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
EP3204358B1 (en)	2014-10-07	2018-09-19	Vertex Pharmaceuticals Incorporated	Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8814458D0 (en) *	1988-06-17	1988-07-20	Wyeth John & Brother Ltd	Heterocyclic compounds
GB9208511D0 (en) *	1991-05-09	1992-06-03	Ici Plc	Compounds
GB9109972D0 (en) *	1991-05-09	1991-07-03	Ici Plc	Therapeutic compounds
IL111266A (en) *	1993-10-22	2002-03-10	Zeneca Ltd	2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9422894D0 (en) *	1994-11-12	1995-01-04	Zeneca Ltd	Pyridazino quinoline compounds
GB9507318D0 (en) *	1995-04-07	1995-05-31	Zeneca Ltd	Alpha substituted pyridazino quinoline compounds

1994
- 1994-10-12 IL IL11126694A patent/IL111266A/xx not_active IP Right Cessation
- 1994-10-12 GB GB9420590A patent/GB9420590D0/en active Pending
- 1994-10-20 NZ NZ329303A patent/NZ329303A/xx not_active IP Right Cessation
- 1994-10-20 JP JP51152195A patent/JP3583132B2/ja not_active Expired - Fee Related
- 1994-10-20 SI SI9430476T patent/SI1004582T1/xx unknown
- 1994-10-20 MY MYPI94002796A patent/MY124316A/en unknown
- 1994-10-20 SK SK504-96A patent/SK282491B6/sk not_active IP Right Cessation
- 1994-10-20 UA UA96041567A patent/UA60291C2/uk unknown
- 1994-10-20 AT AT94930275T patent/ATE198072T1/de not_active IP Right Cessation
- 1994-10-20 PL PL94314041A patent/PL180679B1/pl not_active IP Right Cessation
- 1994-10-20 DK DK00101917T patent/DK1004582T3/da active
- 1994-10-20 RU RU96109470/04A patent/RU2168511C2/ru not_active IP Right Cessation
- 1994-10-20 SG SG1996007261A patent/SG59971A1/en unknown
- 1994-10-20 NZ NZ275472A patent/NZ275472A/en not_active IP Right Cessation
- 1994-10-20 US US08/637,641 patent/US5744471A/en not_active Expired - Fee Related
- 1994-10-20 EP EP94930275A patent/EP0724583B1/en not_active Expired - Lifetime
- 1994-10-20 AU AU79440/94A patent/AU688393B2/en not_active Ceased
- 1994-10-20 PT PT94930275T patent/PT724583E/pt unknown
- 1994-10-20 PT PT00101917T patent/PT1004582E/pt unknown
- 1994-10-20 DK DK94930275T patent/DK0724583T3/da active
- 1994-10-20 SG SG9900943A patent/SG92630A1/en unknown
- 1994-10-20 EP EP00101917A patent/EP1004582B1/en not_active Expired - Lifetime
- 1994-10-20 KR KR1019960702011A patent/KR100261209B1/ko not_active Expired - Fee Related
- 1994-10-20 HU HU9600889A patent/HUT74161A/hu unknown
- 1994-10-20 MY MYPI98002508A patent/MY132875A/en unknown
- 1994-10-20 CN CN94194578A patent/CN1053189C/zh not_active Expired - Fee Related
- 1994-10-20 CZ CZ19961138A patent/CZ292311B6/cs not_active IP Right Cessation
- 1994-10-20 AT AT00101917T patent/ATE295846T1/de not_active IP Right Cessation
- 1994-10-20 SI SI9430314T patent/SI0724583T1/xx unknown
- 1994-10-20 DE DE69426422T patent/DE69426422T2/de not_active Expired - Fee Related
- 1994-10-20 WO PCT/GB1994/002295 patent/WO1995011244A1/en not_active Ceased
- 1994-10-20 ES ES94930275T patent/ES2154686T3/es not_active Expired - Lifetime
- 1994-10-20 CA CA002171332A patent/CA2171332A1/en not_active Abandoned
- 1994-10-20 ES ES00101917T patent/ES2241513T3/es not_active Expired - Lifetime
- 1994-10-20 DE DE69434380T patent/DE69434380T2/de not_active Expired - Fee Related
- 1994-11-18 TW TW083110721A patent/TW406082B/zh not_active IP Right Cessation
1996
- 1996-04-18 FI FI961696A patent/FI113865B/fi active
- 1996-04-19 NO NO961584A patent/NO306995B1/no not_active IP Right Cessation
1997
- 1997-03-03 FI FI970907A patent/FI114916B/fi active IP Right Grant
1998
- 1998-03-19 US US09/044,109 patent/US6232313B1/en not_active Expired - Fee Related
- 1998-05-27 AU AU68999/98A patent/AU721139B2/en not_active Ceased
1999
- 1999-12-06 US US09/455,096 patent/US6103721A/en not_active Expired - Fee Related
2000
- 2000-12-14 GR GR20000402690T patent/GR3035080T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL111266A0 (en)	1994-12-29
EP0724583A1 (en)	1996-08-07
PL180679B1 (en)	2001-03-30
EP1004582B1 (en)	2005-05-18
HK1013997A1 (en)	1999-09-17
CN1138332A (zh)	1996-12-18
MY124316A (en)	2006-06-30
FI114916B (fi)	2005-01-31
SK50496A3 (en)	1997-03-05
NZ329303A (en)	2000-01-28
HU9600889D0 (en)	1996-06-28
US5744471A (en)	1998-04-28
FI970907A0 (fi)	1997-03-03
FI113865B (fi)	2004-06-30
SG92630A1 (en)	2002-11-19
DE69426422D1 (de)	2001-01-18
ES2241513T3 (es)	2005-11-01
NZ275472A (en)	1998-03-25
SK282491B6 (sk)	2002-02-05
US6232313B1 (en)	2001-05-15
AU688393B2 (en)	1998-03-12
NO961584L (no)	1996-04-19
SI0724583T1 (en)	2001-04-30
EP0724583B1 (en)	2000-12-13
PT724583E (pt)	2001-03-30
US6103721A (en)	2000-08-15
RU2168511C2 (ru)	2001-06-10
SI1004582T1 (da)	2005-08-31
CA2171332A1 (en)	1995-04-27
CZ113896A3 (en)	1996-09-11
UA60291C2 (uk)	2003-10-15
FI970907L (fi)	1997-03-03
CZ292311B6 (cs)	2003-09-17
KR100261209B1 (ko)	2000-09-01
FI961696L (fi)	1996-04-18
JP3583132B2 (ja)	2004-10-27
DE69434380D1 (de)	2005-06-23
IL111266A (en)	2002-03-10
NO306995B1 (no)	2000-01-24
SG59971A1 (en)	1999-02-22
ATE295846T1 (de)	2005-06-15
ATE198072T1 (de)	2000-12-15
DE69434380T2 (de)	2006-05-04
AU721139B2 (en)	2000-06-22
HUT74161A (en)	1996-11-28
DK1004582T3 (da)	2005-08-15
EP1004582A2 (en)	2000-05-31
EP1004582A3 (en)	2000-08-30
AU7944094A (en)	1995-05-08
GB9420590D0 (en)	1994-11-30
GR3035080T3 (en)	2001-03-30
ES2154686T3 (es)	2001-04-16
DE69426422T2 (de)	2001-05-10
PT1004582E (pt)	2005-09-30
TW406082B (en)	2000-09-21
WO1995011244A1 (en)	1995-04-27
JPH09504519A (ja)	1997-05-06
AU6899998A (en)	1998-07-30
PL314041A1 (en)	1996-08-05
FI961696A0 (fi)	1996-04-18
NO961584D0 (no)	1996-04-19
MY132875A (en)	2007-10-31
CN1053189C (zh)	2000-06-07

Publication	Publication Date	Title
DK0724583T3 (da)	2001-03-05	Pyridazino-quinolin-forbindelser
ATE237596T1 (de)	2003-05-15	Chinazolinderivate und deren verwendung als vegf hemmer
EP1447405A4 (en)	2005-01-12	CHINOLIN OR CHINAZOLINE DERIVATIVES THAT PREVENT THE AUTOPHOSPHORYLATION OF RECEPTORS FOR THE FIBROBLAST GROWTH FACTOR
DE69428476D1 (de)	2001-11-08	Heterocyclische Verbindungen als Bradykinin Antagonisten
DK0589924T3 (da)	1996-09-30	Fluoralkoxybenzylaminoderivater af nitrogenholdige heterocyclusser
GB9625045D0 (en)	1997-01-22	Parasiticidal compounds
ES8600288A1 (es)	1985-10-01	Un procedimiento para la preparacion de derivados de quinolina.
ATE216584T1 (de)	2002-05-15	Xanthine-derivate als antidepressiva
EA199900927A1 (ru)	2000-08-28	Трициклические соединения
ATE282622T1 (de)	2004-12-15	Kondensierte pyrazolverbindungen
ES2132245T3 (es)	1999-08-16	Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
ATE132136T1 (de)	1996-01-15	Antitumor anthracenderivate
DE69316392D1 (de)	1998-02-19	Azanoradamantane
DE69011714D1 (de)	1994-09-29	Kalziumantagonisten.
EA199800062A1 (ru)	1998-08-27	Новые гетероциклические соединения для лечения боли и их применение
ATE404558T1 (de)	2008-08-15	Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen